100
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Patients’ attitudes toward treatment withdrawal in inflammatory bowel disease

, , &
Page 1428 | Received 23 Jul 2018, Accepted 04 Aug 2018, Published online: 09 Oct 2018

References

  • Doherty G, Katsanos KH, Burisch J, et al. European Crohn’s and colitis organisation topical review on treatment withdrawal [‘exit strategies’] in inflammatory bowel disease. J Crohn’s Colitis. 2018;12:17–31.
  • Biroulet LP, Ferrante M, Magro F, et al. Results from the 2nd scientific workshop of the ECCO (I): impact of mucosal healing on the course of inflammatory bowel disease. J Crohn’s Colitis. 2011;5:477–483.
  • Lopez A, Mounier M, Bouvier AM, et al. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:1324–1329.
  • Kotlyar DS, Lewis JD, Beaugerie L, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2015;13:847–858.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.